We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBA
3801
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$16K ﹤0.01%
457
+157
+52% +$5.4K
QUMU
3802
DELISTED
Qumu Corp.
QUMU
$16K ﹤0.01%
4,595
+4,343
+1,723% +$9.94K
DISCB
3803
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$16K ﹤0.01%
428
+344
+410% +$12.9K
MRLN
3804
DELISTED
Marlin Business Services Corp
MRLN
$16K ﹤0.01%
1,873
+1,803
+2,576% +$14K
YELL
3805
DELISTED
Yellow Corporation Common Stock
YELL
$16K ﹤0.01%
8,622
+4,125
+92% +$6.72K
VEDL
3806
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$16K ﹤0.01%
2,884
-329
-10% -$1.55K
CHU
3807
DELISTED
China Unicom (HONG KONG) Limited
CHU
$16K ﹤0.01%
2,931
-3,578
-55% -$21.8K
BCLI
3808
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$15K ﹤0.01%
88
-691
-89% -$74.5K
BGFV
3809
DELISTED
Big 5 Sporting Goods
BGFV
$15K ﹤0.01%
+7,542
New +$11.3K
BIB icon
3810
ProShares Ultra NASDAQ Biotechnology
BIB
$88.2M
$15K ﹤0.01%
200
-680
-77% -$43.4K
CRNT icon
3811
Ceragon Networks
CRNT
$192M
$15K ﹤0.01%
6,646
-1,145
-15% -$2.41K
HHH icon
3812
Howard Hughes
HHH
$3.91B
$15K ﹤0.01%
294
-1,341
-82% -$67.5K
HP icon
3813
Helmerich & Payne
HP
$4.18B
$15K ﹤0.01%
725
+591
+441% +$11.5K
KRUS icon
3814
Kura Sushi USA
KRUS
$590M
$15K ﹤0.01%
1,078
+320
+42% +$4.58K
LSTA icon
3815
Lisata Therapeutics
LSTA
$9.82M
$15K ﹤0.01%
+544
New +$16K
MEC icon
3816
Mayville Engineering Co
MEC
$584M
$15K ﹤0.01%
+1,958
New +$12K
MTCH icon
3817
Match Group
MTCH
$8.43B
$15K ﹤0.01%
139
-207
-60% -$17.3K
OMF icon
3818
OneMain Financial
OMF
$7.27B
$15K ﹤0.01%
626
+134
+27% +$3.05K
ON icon
3819
ON Semiconductor
ON
$31.1B
$15K ﹤0.01%
762
-10,166
-93% -$166K
ORIC icon
3820
Oric Pharmaceuticals
ORIC
$1.41B
$15K ﹤0.01%
+438
New +$14K
PAC icon
3821
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$15K ﹤0.01%
+209
New +$13.3K
PAM icon
3822
Pampa Energía
PAM
$4.43B
$15K ﹤0.01%
1,455
-1,477
-50% -$15.7K
PSLV icon
3823
Sprott Physical Silver Trust
PSLV
$13.7B
$15K ﹤0.01%
2,200
– –
LNAI
3824
Lunai Bioworks
LNAI
$10.7M
$15K ﹤0.01%
+43
New +$13K
RVLV icon
3825
Revolve Group
RVLV
$1.73B
$15K ﹤0.01%
1,052
-4,411
-81% -$57.9K
151 152
153
154 155

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.